Cargando…
The Duration of Impella 2.5 Circulatory Support and Length of Hospital Stay of Patients Undergoing High-risk Percutaneous Coronary Interventions
BACKGROUND: To evaluate the impact of duration of Impella 2.5 support (Abiomed, Danvers, MA) on hospitalization of patients after high-risk percutaneous coronary intervention (PCI). There has been a continuous increase in prevalence of coronary artery disease with more patients needing PCI during ac...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358206/ https://www.ncbi.nlm.nih.gov/pubmed/28348680 http://dx.doi.org/10.4021/cr190e |
_version_ | 1782516187696988160 |
---|---|
author | Anusionwu, Obiora Fischman, Daniel Cheriyath, Pramil |
author_facet | Anusionwu, Obiora Fischman, Daniel Cheriyath, Pramil |
author_sort | Anusionwu, Obiora |
collection | PubMed |
description | BACKGROUND: To evaluate the impact of duration of Impella 2.5 support (Abiomed, Danvers, MA) on hospitalization of patients after high-risk percutaneous coronary intervention (PCI). There has been a continuous increase in prevalence of coronary artery disease with more patients needing PCI during acute myocardial infarction. Some of these patients have to undergo high-risk revascularization with circulatory support like the Impella 2.5 device. METHODS: This study was a single center retrospective study of patients admitted to our hospital who required Impella circulatory support during percutaneous coronary intervention. Patients’ medical records, cardiac catheterization laboratory and 2-D echocardiography reports were reviewed to ascertain left ventricular ejection fraction, duration of Impella support, Coronary Care Unit (CCU) days and the length of stay in the hospital. A P-value of ≤ 0.05 was considered statistically significant. RESULTS: Over a 15-month period, we had 25 patients with 19 males and 6 females. Mean age of the patient cohort was 68 ± 10 years. Mean LVEF of the group was 32 ± 16%. Mean length of hospital stay was 8 ± 8 days and mean CCU stay was 4 ± 4 days. The Impella was successfully inserted in all cases with a median duration of support of 70 minutes (range, 4 - 5760 minutes). Bleeding complication occurred in 8%. Spearman's rank correlation coefficient between the duration of Impella support and hospital stay was 0.49 (P = 0.023) while it was 0.71 (P = 0.001) between Impella support duration and CCU days. CONCLUSIONS: Our study suggests that there is a positive correlation between the duration of Impella 2.5 circulatory support and hospital stay and/or CCU days. The correlation seems to be stronger with CCU days. |
format | Online Article Text |
id | pubmed-5358206 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Elmer Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-53582062017-03-27 The Duration of Impella 2.5 Circulatory Support and Length of Hospital Stay of Patients Undergoing High-risk Percutaneous Coronary Interventions Anusionwu, Obiora Fischman, Daniel Cheriyath, Pramil Cardiol Res Original Article BACKGROUND: To evaluate the impact of duration of Impella 2.5 support (Abiomed, Danvers, MA) on hospitalization of patients after high-risk percutaneous coronary intervention (PCI). There has been a continuous increase in prevalence of coronary artery disease with more patients needing PCI during acute myocardial infarction. Some of these patients have to undergo high-risk revascularization with circulatory support like the Impella 2.5 device. METHODS: This study was a single center retrospective study of patients admitted to our hospital who required Impella circulatory support during percutaneous coronary intervention. Patients’ medical records, cardiac catheterization laboratory and 2-D echocardiography reports were reviewed to ascertain left ventricular ejection fraction, duration of Impella support, Coronary Care Unit (CCU) days and the length of stay in the hospital. A P-value of ≤ 0.05 was considered statistically significant. RESULTS: Over a 15-month period, we had 25 patients with 19 males and 6 females. Mean age of the patient cohort was 68 ± 10 years. Mean LVEF of the group was 32 ± 16%. Mean length of hospital stay was 8 ± 8 days and mean CCU stay was 4 ± 4 days. The Impella was successfully inserted in all cases with a median duration of support of 70 minutes (range, 4 - 5760 minutes). Bleeding complication occurred in 8%. Spearman's rank correlation coefficient between the duration of Impella support and hospital stay was 0.49 (P = 0.023) while it was 0.71 (P = 0.001) between Impella support duration and CCU days. CONCLUSIONS: Our study suggests that there is a positive correlation between the duration of Impella 2.5 circulatory support and hospital stay and/or CCU days. The correlation seems to be stronger with CCU days. Elmer Press 2012-08 2012-07-20 /pmc/articles/PMC5358206/ /pubmed/28348680 http://dx.doi.org/10.4021/cr190e Text en Copyright 2012, Anusionwu et al. http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Anusionwu, Obiora Fischman, Daniel Cheriyath, Pramil The Duration of Impella 2.5 Circulatory Support and Length of Hospital Stay of Patients Undergoing High-risk Percutaneous Coronary Interventions |
title | The Duration of Impella 2.5 Circulatory Support and Length of Hospital Stay of Patients Undergoing High-risk Percutaneous Coronary Interventions |
title_full | The Duration of Impella 2.5 Circulatory Support and Length of Hospital Stay of Patients Undergoing High-risk Percutaneous Coronary Interventions |
title_fullStr | The Duration of Impella 2.5 Circulatory Support and Length of Hospital Stay of Patients Undergoing High-risk Percutaneous Coronary Interventions |
title_full_unstemmed | The Duration of Impella 2.5 Circulatory Support and Length of Hospital Stay of Patients Undergoing High-risk Percutaneous Coronary Interventions |
title_short | The Duration of Impella 2.5 Circulatory Support and Length of Hospital Stay of Patients Undergoing High-risk Percutaneous Coronary Interventions |
title_sort | duration of impella 2.5 circulatory support and length of hospital stay of patients undergoing high-risk percutaneous coronary interventions |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358206/ https://www.ncbi.nlm.nih.gov/pubmed/28348680 http://dx.doi.org/10.4021/cr190e |
work_keys_str_mv | AT anusionwuobiora thedurationofimpella25circulatorysupportandlengthofhospitalstayofpatientsundergoinghighriskpercutaneouscoronaryinterventions AT fischmandaniel thedurationofimpella25circulatorysupportandlengthofhospitalstayofpatientsundergoinghighriskpercutaneouscoronaryinterventions AT cheriyathpramil thedurationofimpella25circulatorysupportandlengthofhospitalstayofpatientsundergoinghighriskpercutaneouscoronaryinterventions AT anusionwuobiora durationofimpella25circulatorysupportandlengthofhospitalstayofpatientsundergoinghighriskpercutaneouscoronaryinterventions AT fischmandaniel durationofimpella25circulatorysupportandlengthofhospitalstayofpatientsundergoinghighriskpercutaneouscoronaryinterventions AT cheriyathpramil durationofimpella25circulatorysupportandlengthofhospitalstayofpatientsundergoinghighriskpercutaneouscoronaryinterventions |